精鼎医药-话题@MedSci - 梅斯（MedSci）

#精鼎医药#

15篇内容 | 947人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1950421, encodeId=74141950421a1, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=精鼎医药在WCG CenterWatch全球研究中心关系调研中被评为 "值得合作的CRO", objectType=article, longId=294185, objectId=e70429418531, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e70429418531, replyNumber=0, likeNumber=68, createdTime=2022-07-07, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e70429418531, moduleTitle=精鼎医药在WCG CenterWatch全球研究中心关系调研中被评为 "值得合作的CRO", moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e70429418531)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950418, encodeId=09371950418d4, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=精鼎医药与北京病痛挑战公益基金会建立创新合作，助力提升患者在临床试验中的体验, objectType=article, longId=209815, objectId=a6962098152d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6962098152d, replyNumber=0, likeNumber=104, createdTime=2021-09-06, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6962098152d, moduleTitle=精鼎医药与北京病痛挑战公益基金会建立创新合作，助力提升患者在临床试验中的体验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a6962098152d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950420, encodeId=44d3195042073, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=精鼎医药任命前GSK高管Stephen Pyke，为临床数据和数字化服务能力加码, objectType=article, longId=209841, objectId=90a220984160, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90a220984160, replyNumber=0, likeNumber=89, createdTime=2022-01-27, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90a220984160, moduleTitle=精鼎医药任命前GSK高管Stephen Pyke，为临床数据和数字化服务能力加码, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=90a220984160)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950415, encodeId=34c31950415ca, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=ISR发布CRO II/III期基准报告，精鼎医药在多项评估中名列前茅, objectType=article, longId=210361, objectId=0a702103613f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a702103613f, replyNumber=0, likeNumber=64, createdTime=2021-11-14, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a702103613f, moduleTitle=ISR发布CRO II/III期基准报告，精鼎医药在多项评估中名列前茅, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0a702103613f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950414, encodeId=8351195041470, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=精鼎医药任命克莱尔·格雷斯为公司首席患者官，将助力推进以“患者为中心”的临床研究, objectType=article, longId=205651, objectId=d0492056511e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0492056511e, replyNumber=0, likeNumber=0, createdTime=2021-02-01, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0492056511e, moduleTitle=精鼎医药任命克莱尔·格雷斯为公司首席患者官，将助力推进以“患者为中心”的临床研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d0492056511e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950419, encodeId=01c6195041997, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=精鼎医药携手中国医学科学院肿瘤医院建立临床开发创新合作：以患者为中心，提升临床试验的可及性和效率, objectType=article, longId=209986, objectId=90ad209986a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90ad209986a8, replyNumber=0, likeNumber=90, createdTime=2021-06-02, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90ad209986a8, moduleTitle=精鼎医药携手中国医学科学院肿瘤医院建立临床开发创新合作：以患者为中心，提升临床试验的可及性和效率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=90ad209986a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950413, encodeId=3b6e195041304, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=精鼎医药荣获Scrip“更佳合同研究组织”称号, objectType=article, longId=204244, objectId=6a862042443b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a862042443b, replyNumber=0, likeNumber=62, createdTime=2021-07-09, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a862042443b, moduleTitle=精鼎医药荣获Scrip“更佳合同研究组织”称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6a862042443b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950412, encodeId=16b41950412a9, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=精鼎医药全球患者咨询委员会落地中国，推动以患者为中心的药物开发, objectType=article, longId=200515, objectId=12af200515fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12af200515fe, replyNumber=0, likeNumber=69, createdTime=2021-07-02, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12af200515fe, moduleTitle=精鼎医药全球患者咨询委员会落地中国，推动以患者为中心的药物开发, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=12af200515fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950416, encodeId=26ed19504162a, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=EQT私募股权投资基金和高盛资产管理公司与精鼎医药达成收购协议, objectType=article, longId=210480, objectId=8873210480eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8873210480eb, replyNumber=0, likeNumber=53, createdTime=2021-11-15, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8873210480eb, moduleTitle=EQT私募股权投资基金和高盛资产管理公司与精鼎医药达成收购协议, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8873210480eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950417, encodeId=a0f0195041e73, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=精鼎医药继续扩展亚太业务，为临床试验用品供应和物流服务能力加码, objectType=article, longId=189159, objectId=72291891594c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72291891594c, replyNumber=0, likeNumber=96, createdTime=2020-11-27, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72291891594c, moduleTitle=精鼎医药继续扩展亚太业务，为临床试验用品供应和物流服务能力加码, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=72291891594c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950411, encodeId=4ab5195041143, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=重磅！精鼎医药成立法规和市场准入咨询服务专业团队，帮助客户更高效地向患者提供创新疗法, objectType=article, longId=186411, objectId=04c6186411ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04c6186411ea, replyNumber=0, likeNumber=96, createdTime=2020-10-30, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04c6186411ea, moduleTitle=重磅！精鼎医药成立法规和市场准入咨询服务专业团队，帮助客户更高效地向患者提供创新疗法, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=04c6186411ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950408, encodeId=9db5195040882, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=精鼎医药在港成立Health Advances亚洲分公司拓展亚太市场业务, objectType=article, longId=176052, objectId=89f11e605222, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89f11e605222, replyNumber=0, likeNumber=71, createdTime=2020-03-09, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89f11e605222, moduleTitle=精鼎医药在港成立Health Advances亚洲分公司拓展亚太市场业务, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=89f11e605222)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950410, encodeId=f0291950410a2, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=精鼎医药成立法规和市场准入咨询服务专业团队，帮助客户更高效地向患者提供创新疗法, objectType=article, longId=186369, objectId=4bf618636941, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bf618636941, replyNumber=0, likeNumber=67, createdTime=2020-02-13, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bf618636941, moduleTitle=精鼎医药成立法规和市场准入咨询服务专业团队，帮助客户更高效地向患者提供创新疗法, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4bf618636941)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950409, encodeId=ca2419504090b, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=精鼎医药成立早期临床研究联盟，扩大在大中华地区的Ⅰ期临床研究能力, objectType=article, longId=179598, objectId=9c791e9598f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c791e9598f4, replyNumber=0, likeNumber=101, createdTime=2020-04-25, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c791e9598f4, moduleTitle=精鼎医药成立早期临床研究联盟，扩大在大中华地区的Ⅰ期临床研究能力, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9c791e9598f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950407, encodeId=623f195040e04, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, objectTitle=精鼎医药携手CLARINESS 提升中国临床试验患者招募能力及患者参与度, objectType=article, longId=172243, objectId=d1171e224316, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1171e224316, replyNumber=0, likeNumber=66, createdTime=2019-09-06, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1171e224316, moduleTitle=精鼎医药携手CLARINESS 提升中国临床试验患者招募能力及患者参与度, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d1171e224316)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

精鼎医药

2020-05-29

echonoir (审核中...)

前往app查看评论内容

#精鼎医药#

精鼎医药在WCG CenterWatch全球研究中心关系调研中被评为 "值得合作的CRO"

2022-07-07

heli0118 (审核中...)

前往app查看评论内容

#精鼎医药#

精鼎医药与北京病痛挑战公益基金会建立创新合作，助力提升患者在临床试验中的体验

2021-09-06

echonoir (审核中...)

前往app查看评论内容

#精鼎医药#

精鼎医药任命前GSK高管Stephen Pyke，为临床数据和数字化服务能力加码

2022-01-27

heli0118 (审核中...)

前往app查看评论内容

#精鼎医药#

ISR发布CRO II/III期基准报告，精鼎医药在多项评估中名列前茅

2021-11-14

heli0118 (审核中...)

前往app查看评论内容

#精鼎医药#

精鼎医药任命克莱尔·格雷斯为公司首席患者官，将助力推进以“患者为中心”的临床研究

2021-02-01

heli0118 (审核中...)

前往app查看评论内容

#精鼎医药#

精鼎医药携手中国医学科学院肿瘤医院建立临床开发创新合作：以患者为中心，提升临床试验的可及性和效率

2021-06-02

heli0118 (审核中...)

前往app查看评论内容

#精鼎医药#

精鼎医药荣获Scrip“更佳合同研究组织”称号

2021-07-09

heli0118 (审核中...)

前往app查看评论内容

#精鼎医药#

精鼎医药全球患者咨询委员会落地中国，推动以患者为中心的药物开发

2021-07-02

heli0118 (审核中...)

前往app查看评论内容

#精鼎医药#

EQT私募股权投资基金和高盛资产管理公司与精鼎医药达成收购协议

2021-11-15

heli0118 (审核中...)

前往app查看评论内容

#精鼎医药#

精鼎医药继续扩展亚太业务，为临床试验用品供应和物流服务能力加码

2020-11-27

heli0118 (审核中...)

前往app查看评论内容

#精鼎医药#

重磅！精鼎医药成立法规和市场准入咨询服务专业团队，帮助客户更高效地向患者提供创新疗法

2020-10-30

echonoir (审核中...)

前往app查看评论内容

#精鼎医药#

精鼎医药在港成立Health Advances亚洲分公司拓展亚太市场业务

2020-03-09

heli0118 (审核中...)

前往app查看评论内容

#精鼎医药#

精鼎医药成立法规和市场准入咨询服务专业团队，帮助客户更高效地向患者提供创新疗法

2020-02-13

echonoir (审核中...)

前往app查看评论内容

#精鼎医药#

精鼎医药成立早期临床研究联盟，扩大在大中华地区的Ⅰ期临床研究能力

2020-04-25

echonoir (审核中...)

前往app查看评论内容

#精鼎医药#

精鼎医药携手CLARINESS 提升中国临床试验患者招募能力及患者参与度

2019-09-06

科室
- - 订阅+
  - 更多科室
工具
服务